Detalhe da pesquisa
1.
Mesothelioma: Pleural, Version 1.2024.
J Natl Compr Canc Netw
; 22(2): 72-81, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503043
2.
Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic.
J Behav Med
; 47(3): 405-421, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418709
3.
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Lancet Oncol
; 24(9): 1002-1017, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657460
4.
A rare FGF5 candidate variant (rs112475347) for predisposition to nonsquamous, nonsmall-cell lung cancer.
Int J Cancer
; 153(2): 364-372, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916144
5.
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
J Natl Compr Canc Netw
; 21(4): 340-350, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015337
6.
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(9): 961-979, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673108
7.
Factors associated with changes in exercise behaviors during the COVID-19 pandemic.
Cancer Causes Control
; 33(7): 939-950, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35554777
8.
Adoption of Patient-Generated Health Data in Oncology: A Report From the NCCN EHR Oncology Advisory Group.
J Natl Compr Canc Netw
; 20(13)2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042190
9.
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(5): 497-530, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545176
10.
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.
BMC Cancer
; 21(1): 510, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957901
11.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
J Natl Compr Canc Netw
; 19(3): 254-266, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668021
12.
Adverse Event Management in Patients with BRAF V600E-Mutant Non-Small Cell Lung Cancer Treated with Dabrafenib plus Trametinib.
Oncologist
; 24(7): 963-972, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30598499
13.
Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.
Oncologist
; 24(6): e251-e259, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30139835
14.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.
J Natl Compr Canc Netw
; 17(12): 1464-1472, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805526
15.
A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population.
BMC Cancer
; 18(1): 115, 2018 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29385999
16.
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.
J Natl Compr Canc Netw
; 16(10): 1171-1182, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323087
17.
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.
J Natl Compr Canc Netw
; 16(7): 807-821, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30006423
18.
Biomarker-Based Treatment Selection in Non-Small Cell Lung Cancer.
J Natl Compr Canc Netw
; 15(5S): 689-691, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28515245
19.
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(4): 504-535, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404761
20.
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
J Natl Compr Canc Netw
; 14(7): 825-36, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27407123